Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element - PubMed (original) (raw)
Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element
C Meitinger et al. J Virol. 1994 Nov.
Abstract
EBNA2 is one of the few genes of Epstein-Barr virus which are necessary for immortalization of human primary B lymphocytes. The EBNA2 protein acts as a transcriptional activator of several viral and cellular genes. For the TP1 promoter, we have shown previously that an EBNA2-responsive element (EBNA2RE) between -258 and -177 relative to the TP1 RNA start site is necessary and sufficient for EBNA2-mediated transactivation and that it binds EBNA2 through a cellular factor. To define the critical cis elements within this region, we cloned EBNA2RE mutants in front of the TP1 minimal promoter fused to the reporter gene for luciferase. Transactivation by EBNA2 was tested by transfection of these mutants in the absence and presence of an EBNA2 expression vector into the established B-cell line BL41-P3HR-1. The analysis revealed that two identical 11-bp motifs and the region 3' of the second 11-bp motif are essential for transactivation by EBNA2. Methylation interference experiments indicated that the same cellular factor in the absence of EBNA2 binds either one (complex I) or both (complex III) 11-bp motifs with different affinities, giving rise to two different specific protein-DNA complexes within the left-hand 54 bp of EBNA2RE. A third specific complex was shown previously to be present only in EBNA2-expressing cells and to contain EBNA2. Analysis of this EBNA2-containing complex revealed the same protection pattern as for complex III, indicating that EBNA2 interacts with DNA through binding of the cellular protein to the 11-bp motifs. Mobility shift assays with the different mutants demonstrated that one 11-bp motif is sufficient for binding the cellular factor, whereas for binding of EBNA2 as well as for efficient transactivation by EBNA2, both 11-bp motifs are required.
Similar articles
- Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
Laux G, Dugrillon F, Eckert C, Adam B, Zimber-Strobl U, Bornkamm GW. Laux G, et al. J Virol. 1994 Nov;68(11):6947-58. doi: 10.1128/JVI.68.11.6947-6958.1994. J Virol. 1994. PMID: 7933076 Free PMC article. - The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
Zimber-Strobl U, Kremmer E, Grässer F, Marschall G, Laux G, Bornkamm GW. Zimber-Strobl U, et al. EMBO J. 1993 Jan;12(1):167-75. doi: 10.1002/j.1460-2075.1993.tb05642.x. EMBO J. 1993. PMID: 8381349 Free PMC article. - Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.
Fuentes-Pananá EM, Ling PD. Fuentes-Pananá EM, et al. J Virol. 1998 Jan;72(1):693-700. doi: 10.1128/JVI.72.1.693-700.1998. J Virol. 1998. PMID: 9420275 Free PMC article. - Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.
Strobl LJ, Höfelmayr H, Stein C, Marschall G, Brielmeier M, Laux G, Bornkamm GW, Zimber-Strobl U. Strobl LJ, et al. Immunobiology. 1997 Dec;198(1-3):299-306. doi: 10.1016/s0171-2985(97)80050-2. Immunobiology. 1997. PMID: 9442401 Review. - EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes.
Zimber-Strobl U, Strobl LJ. Zimber-Strobl U, et al. Semin Cancer Biol. 2001 Dec;11(6):423-34. doi: 10.1006/scbi.2001.0409. Semin Cancer Biol. 2001. PMID: 11669604 Review.
Cited by
- Electrostatic and Hydrophobic Interactions Mediate Single-Stranded DNA Recognition and Acta2 Repression by Purine-Rich Element-Binding Protein B.
Rumora AE, Ferris LA, Wheeler TR, Kelm RJ Jr. Rumora AE, et al. Biochemistry. 2016 May 17;55(19):2794-805. doi: 10.1021/acs.biochem.6b00006. Epub 2016 May 4. Biochemistry. 2016. PMID: 27064749 Free PMC article. - Asymmetric Arginine dimethylation of Epstein-Barr virus nuclear antigen 2 promotes DNA targeting.
Gross H, Barth S, Palermo RD, Mamiani A, Hennard C, Zimber-Strobl U, West MJ, Kremmer E, Grässer FA. Gross H, et al. Virology. 2010 Feb 20;397(2):299-310. doi: 10.1016/j.virol.2009.11.023. Epub 2009 Dec 6. Virology. 2010. PMID: 19969318 Free PMC article. - Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function.
Yue W, Davenport MG, Shackelford J, Pagano JS. Yue W, et al. J Virol. 2004 Apr;78(7):3542-52. doi: 10.1128/jvi.78.7.3542-3552.2004. J Virol. 2004. PMID: 15016877 Free PMC article. - Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
Harada S, Yalamanchili R, Kieff E. Harada S, et al. J Virol. 1998 Dec;72(12):9948-54. doi: 10.1128/JVI.72.12.9948-9954.1998. J Virol. 1998. PMID: 9811732 Free PMC article. - Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
Jiménez-Ramírez C, Brooks AJ, Forshell LP, Yakimchuk K, Zhao B, Fulgham TZ, Sample CE. Jiménez-Ramírez C, et al. J Virol. 2006 Nov;80(22):11200-8. doi: 10.1128/JVI.00897-06. Epub 2006 Sep 6. J Virol. 2006. PMID: 16956945 Free PMC article.
References
- Int J Cancer. 1979 Sep 15;24(3):294-302 - PubMed
- J Virol. 1990 Mar;64(3):1002-13 - PubMed
- J Virol. 1982 Sep;43(3):952-68 - PubMed
- Int J Cancer. 1975 Jul 15;16(1):7-15 - PubMed
- J Mol Biol. 1976 Apr 15;102(3):511-30 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources